Varsha Jain

TitleInstructor
InstitutionThomas Jefferson University
DepartmentRadiation Oncology
Address3941 Commerce Avenue
Willow Grove PA 19090
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Jain V, de Godoy LL, Mohan S, Chawla S, Learned K, Jain G, Wehrli FW, Alonso-Basanta M. Cerebral hemodynamic and metabolic dysregulation in the postradiation brain. J Neuroimaging. 2022 11; 32(6):1027-1043. PMID: 36156829.
      Citations:    
    2. Reddy VK, Jain V, Wilson Ii RJ, Hartner LP, Diamond M, Sebro RA, Weber KL, Maki RG, Shabason JE. Adult Pleomorphic Rhabdomyosarcomas: Assessing Outcomes Associated with Radiotherapy and Chemotherapy Use in the National Cancer Database. Sarcoma. 2021; 2021:9712070. PMID: 33814964.
      Citations:    
    3. Reddy VK, Jain V, Venigalla S, Nimgaokar V, Amurthur A, Lee DY, Sebro RA, Maki RG, Wilson RJ, Weber KL, Shabason JE. Definitive Local Therapy Is Associated with Improved Survival in Metastatic Soft Tissue Sarcomas. Cancers (Basel). 2021 Feb 24; 13(5). PMID: 33668098.
      Citations:    
    4. Butala AA, Jain V, Reddy VK, Sebro RA, Song Y, Karakousis G, Mitchell TC, Lukens JN, Shabason JE. Impact of Tumor-Infiltrating Lymphocytes on Overall Survival in Merkel Cell Carcinoma. Oncologist. 2021 01; 26(1):63-69. PMID: 32886418.
      Citations:    
    5. Harris WB, Zou W, Cheng C, Jain V, Teo BK, Dong L, Feigenberg SJ, Berman AT, Levin WP, Cengel KA, O'Reilly SE. Higher Dose Volumes May Be Better for Evaluating Radiation Pneumonitis in Lung Proton Therapy Patients Compared With Traditional Photon-Based Dose Constraints. Adv Radiat Oncol. 2020 Sep-Oct; 5(5):943-950. PMID: 33083657.
      Citations:    
    6. Jain V, Niezink AGH, Frick M, Doucette A, Mendes A, Simone CB, Langendijk JA, Wijsman R, Feigenberg SJ, Levin W, Cengel KA, van der Schaaf A, Berman AT. Updating Photon-Based Normal Tissue Complication Probability Models for Pneumonitis in Patients With Lung Cancer Treated With Proton Beam Therapy. Pract Radiat Oncol. 2020 Sep - Oct; 10(5):e330-e338. PMID: 32416270.
      Citations:    
    7. Jain V, Irmen P, O'Reilly S, Vogel JH, Lin L, Lin A. Predicted Secondary Malignancies following Proton versus Photon Radiation for Oropharyngeal Cancers. Int J Part Ther. 2020; 6(4):1-10. PMID: 32582814.
      Citations:    
    8. O'Reilly S, Jain V, Huang Q, Cheng C, Teo BK, Yin L, Zhang M, Diffenderfer E, Li T, Levin W, Xiao Y, Dong L, Feigenberg S, Berman AT, Zou W. Dose to Highly Functional Ventilation Zones Improves Prediction of Radiation Pneumonitis for Proton and Photon Lung Cancer Radiation Therapy. Int J Radiat Oncol Biol Phys. 2020 05 01; 107(1):79-87. PMID: 31987966.
      Citations:    
    9. Dbaibo G, Amanullah A, Claeys C, Izu A, Jain VK, Kosalaraksa P, Rivera L, Soni J, Yanni E, Zaman K, Acosta B, Ariza M, Arroba Basanta ML, Bavdekar A, Carmona A, Cousin L, Danier J, Diaz A, Diez-Domingo J, Dinleyici EC, Faust SN, Garcia-Sicilia J, Gomez-Go GD, Gonzales MLA, Hacimustafaoglu M, Hughes SM, Jackowska T, Kant S, Lucero M, Mares Bermudez J, Martin?n-Torres F, Montellano M, Prymula R, Puthanakit T, Ruzkova R, Sadowska-Krawczenko I, Szymanski H, Ulied A, Woo W, Schuind A, Innis BL. Quadrivalent Influenza Vaccine Prevents Illness and Reduces Healthcare Utilization Across Diverse Geographic Regions During Five Influenza Seasons: A Randomized Clinical Trial. Pediatr Infect Dis J. 2020 01; 39(1):e1-e10. PMID: 31725115.
      Citations:    
    10. Jain V, Hwang WT, Venigalla S, Nead KT, Lukens JN, Mitchell TC, Shabason JE. Association of Age with Efficacy of Immunotherapy in Metastatic Melanoma. Oncologist. 2020 02; 25(2):e381-e385. PMID: 32043765.
      Citations:    
    11. Grewal AS, Min EJ, Long Q, Grewal SK, Jain V, Levin WP, Cengel KA, Swisher-McClure S, Aggarwal C, Bauml JM, Singh A, Ciunci C, Cohen RB, Langer C, Feigenberg SJ, Berman AT. Early Tumor and Nodal Response in Patients with Locally Advanced Non-Small Cell Lung Carcinoma Predict for Oncologic Outcomes in Patients Treated with Concurrent Proton Therapy and Chemotherapy. Int J Radiat Oncol Biol Phys. 2020 02 01; 106(2):358-368. PMID: 31654783.
      Citations:    
    12. Jain V, Venigalla S, Sebro RA, Karakousis GC, Wilson RJ, Weber KL, Shabason JE. Association of health insurance status with presentation, treatment and outcomes in soft tissue sarcoma. Cancer Med. 2019 10; 8(14):6295-6304. PMID: 31483578.
      Citations:    
    13. Innis BL, Berlanda Scorza F, Blum JS, Jain VK, Older Aguilar A, Post DJ, Roberts PC, Wairagkar N, White J, Bresee J. Meeting report: Convening on the influenza human viral challenge model for universal influenza vaccines, Part 1: Value; challenge virus selection; regulatory, industry and ethical considerations; increasing standardization, access and capacity. Vaccine. 2019 08 14; 37(35):4823-4829. PMID: 31362819.
      Citations:    
    14. Innis BL, Scorza FB, Blum JS, Jain VK, Aguilar AO, Post DJ, Roberts PC, Wairagkar N, White J, Bresee J. Convening on the influenza human viral challenge model for universal influenza vaccines, Part 2: Methodologic considerations. Vaccine. 2019 08 14; 37(35):4830-4834. PMID: 31362820.
      Citations:    
    15. Danier J, Rivera L, Claeys C, Dbaibo G, Jain VK, Kosalaraksa P, Woo W, Yanni E, Zaman K, Acosta B, Amanullah A, Ariza M, Luisa Arroba Basanta M, Bavdekar A, Carmona A, Cousin L, Diaz A, Diez-Domingo J, Cagri Dinleyici E, Faust SN, Garcia-Sicilia J, Gomez-Go GD, Antionette Gonzales L, Hacimustafaoglu M, Hughes SM, Izu A, Jackowska T, Kant S, Lucero M, Mares Bermudez J, Martin?n-Torres F, Montellano M, Prymula R, Puthanakit T, Ruzkova R, Sadowska-Krawczenko I, Soni J, Szymanski H, Ulied A, Schuind A, Innis BL. Clinical Presentation of Influenza in Children 6 to 35 Months of Age: Findings From a Randomized Clinical Trial of Inactivated Quadrivalent Influenza Vaccine. Pediatr Infect Dis J. 2019 08; 38(8):866-872. PMID: 31306399.
      Citations:    
    16. Jain V, Berman AT. Early Bird Catches the Worm: PORT-A Compelling Treatment Strategy. Int J Radiat Oncol Biol Phys. 2019 07 15; 104(4):711. PMID: 31204655.
      Citations:    
    17. Claeys C, Chandrasekaran V, Garc?a-Sicilia J, Prymula R, D?ez-Domingo J, Brzostek J, Mar?s-Berm?dez J, Martin?n-Torres F, Pollard AJ, Ru?kov? R, Carmona Martinez A, Ulied A, Miranda Valdivieso M, Faust SN, Snape MD, Friel D, Ollinger T, Soni J, Schuind A, Li P, Innis BL, Jain VK. Anamnestic Immune Response and Safety of an Inactivated Quadrivalent Influenza Vaccine in Primed Versus Vaccine-Na?ve Children. Pediatr Infect Dis J. 2019 02; 38(2):203-210. PMID: 30325891.
      Citations:    
    18. Venigalla S, Carmona R, Guttmann DM, Jain V, Freedman GM, Clark AS, Shabason JE. Use and Effectiveness of Adjuvant Endocrine Therapy for Hormone Receptor-Positive Breast Cancer in Men. JAMA Oncol. 2018 10 01; 4(10):e181114. PMID: 29800030.
      Citations:    
    19. Jain V, Berman AT. Radiation Pneumonitis: Old Problem, New Tricks. Cancers (Basel). 2018 Jul 03; 10(7). PMID: 29970850.
      Citations:    
    20. Claeys C, Drame M, Garc?a-Sicilia J, Zaman K, Carmona A, Tran PM, Miranda M, Martin?n-Torres F, Thollot F, Horn M, Schwarz TF, Behre U, Merino JM, Sadowska-Krawczenko I, Szymanski H, Schu P, Neumeier E, Li P, Jain VK, Innis BL. Assessment of an optimized manufacturing process for inactivated quadrivalent influenza vaccine: a phase III, randomized, double-blind, safety and immunogenicity study in children and adults. BMC Infect Dis. 2018 04 18; 18(1):186. PMID: 29669531.
      Citations:    
    21. Claeys C, Zaman K, Dbaibo G, Li P, Izu A, Kosalaraksa P, Rivera L, Acosta B, Arroba Basanta ML, Aziz A, Cabanero MA, Chandrashekaran V, Corsaro B, Cousin L, Diaz A, Diez-Domingo J, Dinleyici EC, Faust SN, Friel D, Garcia-Sicilia J, Gomez-Go GD, Antoinette Gonzales ML, Hughes SM, Jackowska T, Kant S, Lucero M, Malvaux L, Mares Bermudez J, Martinon-Torres F, Miranda M, Montellano M, Peix Sambola MA, Prymula R, Puthanakit T, Ruzkova R, Sadowska-Krawczenko I, Salamanca de la Cueva I, Sokal E, Soni J, Szymanski H, Ulied A, Schuind A, Jain VK, Innis BL. Prevention of vaccine-matched and mismatched influenza in children aged 6-35 months: a multinational randomised trial across five influenza seasons. Lancet Child Adolesc Health. 2018 05; 2(5):338-349. PMID: 30169267.
      Citations:    
    22. Venigalla S, Guttmann DM, Jain V, Sharma S, Freedman GM, Shabason JE. Trends and Patterns of Utilization of Hypofractionated Postmastectomy Radiotherapy: A National Cancer Database Analysis. Clin Breast Cancer. 2018 10; 18(5):e899-e908. PMID: 29550285.
      Citations:    
    23. Ofori-Anyinam O, Leroux-Roels G, Drame M, Aerssens A, Maes C, Amanullah A, Schuind A, Li P, Jain VK, Innis BL. Immunogenicity and safety of an inactivated quadrivalent influenza vaccine co-administered with a 23-valent pneumococcal polysaccharide vaccine versus separate administration, in adults =50years of age: Results from a phase III, randomized, non-inferiority trial. Vaccine. 2017 11 01; 35(46):6321-6328. PMID: 28987445.
      Citations:    
    24. Jain VK, Domachowske JB, Wang L, Ofori-Anyinam O, Rodr?guez-Weber MA, Leonardi ML, Klein NP, Schlichter G, Jeanfreau R, Haney BL, Chu L, Harris JS, Sarpong KO, Micucio AC, Soni J, Chandrasekaran V, Li P, Innis BL. Time to Change Dosing of Inactivated Quadrivalent Influenza Vaccine in Young Children: Evidence From a Phase III, Randomized, Controlled Trial. J Pediatric Infect Dis Soc. 2017 Mar 01; 6(1):9-19. PMID: 28062552.
      Citations:    
    25. Zerbini CA, Ribeiro Dos Santos R, Jose Nunes M, Soni J, Li P, Jain VK, Ofori-Anyinam O. Immunogenicity and safety of Southern Hemisphere inactivated quadrivalent influenza vaccine: a Phase III, open-label study of adults in Brazil. Braz J Infect Dis. 2017 Jan - Feb; 21(1):63-70. PMID: 27912069.
      Citations:    
    26. Bekkat-Berkani R, Ray R, Jain VK, Chandrasekaran V, Innis BL. Evidence update: GlaxoSmithKline's inactivated quadrivalent influenza vaccines. Expert Rev Vaccines. 2016; 15(2):201-14. PMID: 26641539.
      Citations:    
    27. Shi W, Jain V, Kim H, Champ C, Jain G, Farrell C, Andrews DW, Judy K, Liu H, Artz G, Werner-Wasik M, Evans JJ. Fractionated Stereotactic Radiotherapy for Facial Nerve Schwannomas. J Neurol Surg B Skull Base. 2016 Feb; 77(1):75-80. PMID: 26949592.
      Citations:    
    28. Wang L, Chandrasekaran V, Domachowske JB, Li P, Innis BL, Jain VK. Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine in US Children 6-35 Months of Age During 2013-2014: Results From A Phase II Randomized Trial. J Pediatric Infect Dis Soc. 2016 Jun; 5(2):170-9. PMID: 26407273.
      Citations:    
    29. Rodriguez Weber MA, Claeys C, Aranza Doniz C, Feng Y, Innis BL, Jain VK, Peeters M. Immunogenicity and safety of inactivated quadrivalent and trivalent influenza vaccines in children 18-47 months of age. Pediatr Infect Dis J. 2014 Dec; 33(12):1262-9. PMID: 25386965.
      Citations:    
    30. Langley JM, Wang L, Aggarwal N, Bueso A, Chandrasekaran V, Cousin L, Halperin SA, Li P, Liu A, McNeil S, Mendez LP, Rivera L, Innis BL, Jain VK. Immunogenicity and Reactogenicity of an Inactivated Quadrivalent Influenza Vaccine Administered Intramuscularly to Children 6 to 35 Months of Age in 2012-2013: A Randomized, Double-Blind, Controlled, Multicenter, Multicountry, Clinical Trial. J Pediatric Infect Dis Soc. 2015 Sep; 4(3):242-51. PMID: 26336604.
      Citations:    
    31. Jain VK, Dbaibo G, Innis BL. Vaccine for prevention of influenza in children. N Engl J Med. 2014 03 20; 370(12):1167-8. PMID: 24645953.
      Citations:    
    32. Jain VK, Chandrasekaran V, Wang L, Li P, Liu A, Innis BL. A historically-controlled Phase III study in adults to characterize the acceptability of a process change for manufacturing inactivated quadrivalent influenza vaccine. BMC Infect Dis. 2014 Mar 10; 14:133. PMID: 24606983.
      Citations:    
    33. Tinoco JC, Pavia-Ruz N, Cruz-Valdez A, Aranza Doniz C, Chandrasekaran V, Dew? W, Liu A, Innis BL, Jain VK. Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged =18 years: a phase III, randomized trial. Vaccine. 2014 Mar 14; 32(13):1480-7. PMID: 24486352.
      Citations:    
    34. Jain VK, Rivera L, Zaman K, Espos RA, Sirivichayakul C, Quiambao BP, Rivera-Medina DM, Kerdpanich P, Ceyhan M, Dinleyici EC, Cravioto A, Yunus M, Chanthavanich P, Limkittikul K, Kurugol Z, Alhan E, Caplanusi A, Durviaux S, Boutet P, Ofori-Anyinam O, Chandrasekaran V, Dbaibo G, Innis BL. Vaccine for prevention of mild and moderate-to-severe influenza in children. N Engl J Med. 2013 Dec 26; 369(26):2481-91. PMID: 24328444.
      Citations:    
    35. Kieninger D, Sheldon E, Lin WY, Yu CJ, Bayas JM, Gabor JJ, Esen M, Fernandez Roure JL, Narejos Perez S, Alvarez Sanchez C, Feng Y, Claeys C, Peeters M, Innis BL, Jain V. Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged =18?years. BMC Infect Dis. 2013 Jul 24; 13:343. PMID: 23883186.
      Citations:    
    36. Langley JM, Carmona Martinez A, Chatterjee A, Halperin SA, McNeil S, Reisinger KS, Aggarwal N, Huang LM, Peng CT, Garcia-Sicilia J, Salamanca de la Cueva I, Caba?as F, Trevi?o-Garza C, Rodr?guez-Weber MA, de la O M, Chandrasekaran V, Dew? W, Liu A, Innis BL, Jain VK. Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in children. J Infect Dis. 2013 Aug 15; 208(4):544-53. PMID: 23847058.
      Citations:    
    37. Pavia-Ruz N, Angel Rodriguez Weber M, Lau YL, Nelson EA, Kerdpanich A, Huang LM, Silas P, Qaqundah P, Blatter M, Jeanfreau R, Lei P, Jain V, El Idrissi M, Feng Y, Innis B, Peeters M, Devaster JM. A randomized controlled study to evaluate the immunogenicity of a trivalent inactivated seasonal influenza vaccine at two dosages in children 6 to 35 months of age. Hum Vaccin Immunother. 2013 Sep; 9(9):1978-88. PMID: 23782962.
      Citations:    
    38. Domachowske JB, Pankow-Culot H, Bautista M, Feng Y, Claeys C, Peeters M, Innis BL, Jain V. A randomized trial of candidate inactivated quadrivalent influenza vaccine versus trivalent influenza vaccines in children aged 3-17 years. J Infect Dis. 2013 Jun 15; 207(12):1878-87. PMID: 23470848.
      Citations:    
    39. Domachowske JB, Blatter M, Chandrasekaran V, Liu A, Jain VK, Fries L. A randomized, controlled trial in children to assess the immunogenicity and safety of a thimerosal-free trivalent seasonal influenza vaccine. Pediatr Infect Dis J. 2012 Jun; 31(6):605-15. PMID: 22333695.
      Citations:    
    40. Langley JM, Vanderkooi OG, Garfield HA, Hebert J, Chandrasekaran V, Jain VK, Fries L. Immunogenicity and Safety of 2 Dose Levels of a Thimerosal-Free Trivalent Seasonal Influenza Vaccine in Children Aged 6-35 Months: A Randomized, Controlled Trial. J Pediatric Infect Dis Soc. 2012 Mar; 1(1):55-63. PMID: 23687572.
      Citations:    
    41. Campbell JD, Chambers CV, Brady RC, Caldwell MC, Bennett NL, Fourneau MA, Jain VK, Innis BL. Immunologic non-inferiority of a newly licensed inactivated trivalent influenza vaccine versus an established vaccine: a randomized study in US adults. Hum Vaccin. 2011 Jan 01; 7(1):81-8. PMID: 21285532.
      Citations:    
    42. Baxter R, Jeanfreau R, Block SL, Blatter M, Pichichero M, Jain VK, Dew? W, Innis BL. A Phase III evaluation of immunogenicity and safety of two trivalent inactivated seasonal influenza vaccines in US children. Pediatr Infect Dis J. 2010 Oct; 29(10):924-30. PMID: 20431425.
      Citations:    
    43. Beran J, Wertzova V, Honegr K, Kaliskova E, Havlickova M, Havlik J, Jirincova H, Van Belle P, Jain V, Innis B, Devaster JM. Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete example. BMC Infect Dis. 2009 Jan 17; 9:2. PMID: 19149900.
      Citations:    
    44. Treanor JJ, Campbell JD, Brady RC, Keitel WA, Drame M, Jain VK, Innis BL. Rapid licensure of a new, inactivated influenza vaccine in the United States. Hum Vaccin. 2005 Nov-Dec; 1(6):239-44. PMID: 17012883.
      Citations:    
    Jain's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (143)
    Explore
    _
    Co-Authors (9)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _